Cosyntropin
| Cosyntropin | |
|---|---|
|
L-seryl-L-tyrosyl-L-seryl-L-methionyl-L-α-glutamyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valylglycyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-prolyl-L-valyl-L-lysyl-L-valyl-L-tyrosyl-L-proline |
|
|
Other names
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
|
| Identifiers | |
| CAS number | 16960-16-0 |
| PubChem | 16133751 |
| ChemSpider | 10481947 |
| UNII | 72YY86EA29 |
| DrugBank | DB01284 |
| ChEMBL | CHEMBL1201443 |
|
|
| Properties | |
| Molecular formula | C136H210N40O31S |
| Molar mass | 2933.437 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
Cosyntropin (Cortrosyn) is a synthetic derivative of adrenocorticotropic hormone (ACTH) that is used in the ACTH stimulation test to evaluate and diagnose cortisol disorders. Cosyntropin contains only the first 24 (of a total 39) amino acids of ACTH but retains full function.[1]
In patients with low cortisol levels or symptoms of adrenocortical insufficiency, cosyntropin can be used to diagnose Addison's disease. A failure for serum cortisol levels to increase after administration of cosyntropin makes a diagnosis of primary adrenocortical insufficiency more likely. An increase in cortisol upon administration of cosyntropin rules out the condition.
[edit] See also
[edit] References
[edit] External links
|
||||||||||||||||||||||||||||||||||